Multi-Omics and Radiomics Approaches Uncover a TMSB10-Influenced Cell State for Non-Invasive Evaluation and Precision Classification in Breast Cancer - Summary - MDSpire
Advertisement
Multi-Omics and Radiomics Approaches Uncover a TMSB10-Influenced Cell State for Non-Invasive Evaluation and Precision Classification in Breast Cancer
To delineate breast cancer tumor cell heterogeneity and identify a tumor cell cluster influenced by TMSB10, which is crucial for non-invasive evaluation and precision classification.
Key Findings:
Identification of a poor-prognosis tumor cell cluster (C1) associated with late evolutionary state and metabolic reprogramming, indicating potential therapeutic targets.
High abundance of C1 cluster linked to poor survival and specific somatic mutations, suggesting a need for tailored treatment strategies.
C1 cluster predicted superior response to immune checkpoint blockade but not to chemo/radiotherapy, highlighting its role in immunotherapy.
TMSB10 was confirmed as a core gene promoting proliferation, migration, and invasion, indicating its potential as a therapeutic target.
Interpretation:
The C1 cluster is a key driver of breast cancer progression, influencing treatment responses and providing a target for non-invasive diagnostic and prognostic tools, which could improve patient outcomes.
Limitations:
Limited cohort sizes in previous studies may affect the generalizability of findings, potentially limiting the applicability of results.
Insufficient clinical-translational validation in some aspects of the research, necessitating further studies to confirm findings.
Conclusion:
The study highlights the potential of TMSB10 and the C1 cluster in breast cancer for non-invasive detection and prognostic stratification, paving the way for improved individualized patient management.
